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Abstract
Background:  Recently new aspects of the immunopathology of Chagas disease have been
described in patients infected with HIV and unusual clinical manifestations such as cutaneous
lesions, involvement of central nervous system and/or serious cardiac lesions related to the
reactivation of the parasite have been reported. Two uncloned Trypanosoma cruzi strains previously
isolated from chronic chagasic patients with HIV co-infection were studied in order to evaluate the
impact of the immunosuppression on the genetic diversity of the parasite.
Results: We have exploited an experimental model to determine whether genetically distinct
populations appear after immunosuppression as a consequence of in vivo selection or in vitro
propagation. The in vitro and in vivo conditions have allowed us to study the selected populations.
The first strain was isolated from a case of reactivation of Chagas disease in a patient which
presented four cerebral lesions. It was possible to demonstrate that the patient was infected with
at least three distinct populations of T. cruzi. The population, recovered after immunosuppression,
in mice was genetically divergent from the primary human isolate. The second strain, isolated from
a hemophiliac/HIV positive patient presenting cardiac manifestation of Chagas disease showed no
marked genetic difference after experimental immunosuppression.
Conclusion: The immunological condition of the patient, associated or not to the reactivation of
the infection, and also the strain of the parasite may have an important role during the course of
the disease. The in vivo mechanism that generates parasite genetic variability or the participation of
the selection under stress conditions will require further investigation.
Background
Chagas disease is a zoonosis widely spread in Central and
South America affecting 18 million people in 21 endemic
countries. Approximately 100 million people are exposed
to the risk of infection which corresponds to 25% of all
Latin American inhabitants [1,2]. Trypanosoma cruzi, the
etiologic agent of Chagas disease, is composed of a set of
heterogeneous populations presenting a remarkable
degree of intra-specific heterogeneity. The circulation of
such populations in domestic and sylvatic cycles involve
humans, vectors and animal reservoirs. Initial studies
using isoenzymatic analysis revealed three major zymo-
demes: Z1 and Z3 (found in the sylvatic cycle) and Z2 in
domestic environments [3]. Subsequently the zymodeme
diversity among distinct clones was found indicating that
they could hardly be clustered in a few groups [4]. In
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recent years the committee of the "International sympo-
sium on the advances in knowledge of Chagas disease 90
years after its discovery" [5] decided to classify T. cruzi iso-
lates in two groups: T. cruzi I associated with the sylvatic
cycle and T. cruzi II with the domestic cycle. This intra-spe-
cific heterogeneity has also been demonstrated by differ-
ent genotypic and phenotypic markers, confirming the
multiclonal structure of T. cruzi populations [6–8], prob-
ably having important clinical and epidemiological
impact. As a consequence people living in endemic areas
are frequently exposed to independent multiple infection,
constantly leading to an accumulation of genetic endog-
enous variability [9,10] that contributes to the polyclonal-
ity of primary T. cruzi isolates.
Recently new aspects of the immunopathology of Chagas
disease have been described in patients infected with HIV.
Patients with Chagas disease/ HIV co-infection may
present unusual clinical manifestations such as cutaneous
lesions, involvement of central nervous system and/or
serious cardiac lesions related to the reactivation of the
infection [11–14]. The process of reactivation opens an
interesting field to investigate the genetic variability of T.
cruzi  populations under immunosuppression circum-
stances. Pacheco et al.[15] reported the genotypic and
phenotypic typing of a strain isolated from a case of Cha-
gas disease reactivation associated with AIDS in a patient
presenting involvement of the central nervous system.
Based on the severity of this case, we decided to further
analyze the previously isolated strain investigating the
genetic characteristics of the parasite before and after
immunosuppression in mice. The present paper also
reports the study of a second T. cruzi strain isolated from
a hemophiliac patient suffering from Chagas disease/HIV
co-infection, in order to estimate the impact of the immu-
nosuppression on the genetic diversity of both isolates.
Materials and Methods
Isolates and reference strains
Patient 1: chronic chagasic/ HIV positive patient, from
Minas Gerais State, Brazil, presenting indeterminate form
acquired from natural transmission before the HIV infec-
tion. The CD4 lymphocyte count was 102 mm3, when the
patient died of intracranial hemorrhage [15].
Patient 2: hemophiliac/ HIV positive patient from Bahia
State, Brazil, manifesting cardiac form of Chagas disease
acquired from natural transmission. The CD4 lymphocyte
count was higher than 500 mm3 [16].
Four  T. cruzi reference strains: representing the major
zymodeme groups [17]: Z1 – Dm28c and Colombian (T.
cruzi I), Z2 – CL strain, Z2b – Y strain (T. cruzi II) were
used as control in the molecular typing. The two T. cruzi
strains from Chagas disease/HIV co-infection human
cases were prior isolated by xenodiagnosis and propa-
gated in biphasic cultures (Novy-Nicolle-McNeal – NNN/
Brain Heart Infusion-BHI/ 10% Fetal Bovine Serum, com-
plemented with 20 mg/ml ampicillin, 0.1 mg/ml strepto-
mycin and 100 U/ml penicillin at 28°C. The parasite
growth was accompanied during five passages. The cell
mass was prepared and the parasites characterized by
molecular markers according to protocols previously
described [18–20]. Concomitantly, groups of ten male
Swiss mice weighting 8–10 g were inoculated, intraperito-
neally, with culture forms and examined through fresh
blood slides after 20 days. Mice, presenting patent para-
sitemia, were maintained through passages with 104
bloodstream trypomastigotes, on the 21st day of infection
for five months. After passage in mice, both strains were
re-isolated in biphasic cultures (without antibiotics) at
28°C with serial passages on the 21st day. The primary iso-
lates were kept in culture for twelve months and cryopre-
served in liquid nitrogen.
Immunosuppression
In the chronic phase of the disease (six months of infec-
tion), mice were immunosuppressed with 50 mg of cyclo-
phosphamide per kg of body weight for eighteen
consecutive days [21]. After immunosuppression para-
sites were recovered from the blood and characterized
using molecular approaches.
The experiments in mice were conducted using a protocol
approved by the Center for Biological Evaluation and
Care of Research Animals (CEUA-FIOCRUZ, Program n°
P0067-00) and in accordance with the code of ethics of
the Brazilian College of Animal Experimentation
(COBEA).
Molecular characterization
T. cruzi populations obtained from in vivo and in vitro con-
ditions were compared with the primary uncloned iso-
lates. The cell mass was prepared washing the parasites
twice by centrifugation at 700 × g in SE buffer (0.15 M
NaCl / 0.1 M EDTA, pH 8,0) for 10 min at 4°C. The cell
mass was stored at -70°C before being used for multilocus
enzyme electrophoresis and kDNA analyses.
Multilocus enzyme electrophoresis (MLEE)
Isoenzymatic analyses were performed on 1% agarose gel
according to protocols previously described [17,20]. The
following nine enzymes were used: glucose 6 phosphate
dehydrogenase (G6PDH; E.C. 1.1.49), glucose phosphate
isomerase (GPI; E.C.5.3.1.9), isocitrate dehydrogenase
(IDH; E.C. 1.1.1.42), malate dehydrogenase (MDH;
E.C.1.1.1.37), malic enzyme (ME; E.C.1.1.1.40), nucleoti-
dase (NH, E.C.3.2.2.1), peptidase D (PEP-D,
E.C.3.4.13.9), 6-phosphogluconate dehydrogenase (6PG;
E.C. 1.1.44), phosphoglucomutase (PGM; E.C.2.7.5.1).Kinetoplastid Biology and Disease 2003, 2 http://www.kinetoplastids.com/content/2/1/17
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kDNA restriction profiles and Molecular hybridization
The kDNA extraction and restriction enzyme analyses
were carried out according to the methodology previously
described [18,19].
Approximately 1 µg of purified kDNA was digested by the
restriction enzymes Hinf-I at 37°C for 3 hrs in the appro-
priate buffer. kDNA fragments (maxi and minicircles)
were separated through electrophoresis in 1.5% agarose
gel in TBE buffer (0.89 M Tris-base; 0.89 M boric acid;
0.024 M EDTA). The electrophoretic pattern was visual-
ized under UV light after ethidium bromide staining.
Fragments of kDNA were transferred to a nylon mem-
brane according to Southern [22], the gel having previ-
ously been denatured in 1.5 M NaCl/0.5 M NaOH and
neutralized in 1 M Tris-HCl pH 8.0. Each step was carried
out during 30 min with mild stirring.
The total kDNA from primary isolate of Patient 1, named
as kDNA profile I and populations recovered from in vivo
(kDNA profile II) and in vitro conditions (kDNA profile
III) were radiolabeled with α32 P dATP by the random
primer reaction [23] and used as probes. After hybridiza-
tion, the filters were washed three times during 30 min in
0.1x SSC/ 0.5% SDS at 60°C. Autoradiography was per-
formed using X-ray film (Kodak X-OMAT) at -70°C
overnight.
Numerical Analysis
The isoenzymatic profiles were compared using Simple
Matching (SM) coefficient of similarity to determine the
proportion of mismatched bands. The matrix was trans-
formed into a dendrogram by the UPGMA (unweighted
pair-group method with arithmetic averages) algorithm
[24] using NTSYS program (version 2.0, Exeter Software,
100 North Country Rd, Setauket, NY).
Results
Molecular typing
The primary isolates from both patients were prior charac-
terized by MLEE and restriction analyses of kDNA reveal-
ing distinct zymodemes and kDNA restriction profiles.
Numerical analysis based on patterns generated by nine
enzymatic systems has allowed the division of the strains
into two clusters separated by a coefficient of similarity of
0.73. The first cluster was formed by the strain isolated
from Patient 1 and T. cruzi strains representative of
domestic zymodemes (Z2) sharing different coefficients
of similarity (from 0.82 to 0.94). No T. cruzi strains ana-
lyzed was found to be 100% similar (SM = 1). The strain
isolated from Patient 1 was identified as isoenzymatic var-
iant of the reference strains (CL and Y) associated with the
domestic cycle (Z2). The sylvatic Z1 zymodeme (repre-
sented by the T. cruzi strains Dm28c and Colombian) was
included in the second cluster sharing approximately 85%
of common characteristics. The strain from Patient 2, con-
sidered the most differentiated, was linked to the two
main clusters by a coefficient of 0.60 (Fig. 1). The isoenzy-
matic pattern observed for such strain was compatible
with strains belonging to sylvatic zymodemes in four
(PGM, GPI, PEP-D and 6PG) out of the nine enzymes
Dendrogram showing the Simple Matching Coefficient (SM) of similarity based on isoenzymatic profiles of the T. cruzi strains  from Chagas disease/HIV co-infection patients and comparison with other different T. cruzi strains Figure 1
Dendrogram showing the Simple Matching Coefficient (SM) of similarity based on isoenzymatic profiles of the T. cruzi strains 
from Chagas disease/HIV co-infection patients and comparison with other different T. cruzi strains. Patient 1; B-T. cruzi isolated 
from a chronic chagasic patient, Y-prototype of Z2b (Y strain), CL-prototype of Z2 (CL strain), E-T. cruzi isolated from vector, 
Dm28c and Colombian strains-prototypes of Z1, Patient 2.Kinetoplastid Biology and Disease 2003, 2 http://www.kinetoplastids.com/content/2/1/17
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tested.
kDNA Analyses
Hinf-I restriction analysis of kDNA has demonstrated the
presence of three different genotypic profiles when the
primary isolate from Patient 1 (kDNA profile I) and para-
site populations from in vivo (kDNA profile II) and in vitro
(kDNA profile III) conditions were compared. In fact
three different parasite subpopulations were selected from
Patient 1 (Fig. 2A, lanes 1, 2 and 3). The genotypic profiles
of the populations that emerged in vivo and in vitro were
distinct. However, only one genetic pattern was detected
after immunosuppression in mice, independent of the
initial inoculum (Fig. 2A, lanes 4 and 5). In figure 2B the
region of minicircle fragments ranging from 600 to 1500
bp was amplified to better visualize the kDNA polymor-
phisms. Polymorphisms were not detected in kDNA frag-
ments of the parasite isolated from Patient 2, before and
after immunosuppression (not shown).
The genotypic differences observed in the kDNA restric-
tion profiles (kDNA profiles I, II and III) were also evalu-
ated in cross hybridization experiments using the same
kDNA profiles as homologous probes (Fig. 3). When
kDNA profile I (Patient 1) was used as probe, a strong
sequence homology with the homologous kDNA and
with sequence from profile II populations was detected
(Fig. 3B, lanes 1 and 2). However an absence of cross-
homology with kDNA from in vitro populations (profile
III) was perceived (Fig. 3B, lane 3). Curiously, the probe
prepared from kDNA profile III only hybridizes with its
homologous sequences and with those from kDNA pro-
file I (Fig. 3C, lanes 1 and 3). Interestingly the kDNA
probe prepared from parasites recovered after passage in
immunosuppressed mice (kDNA profile II) did not recog-
nize homologous sequences in kDNA profile III (Fig. 3D,
lane 3).
Isoenzymatic patterns
Analysis of nine enzymatic systems (G6P, GPI, IDH,
MDH, ME, NH, PEP-D, 6PG, PGM) revealed no evident
isoenzymatic variation among the primary isolate from
Patient 1 and populations recovered after passage in
immunosuppressed mice. Distinct isoenzymatic variation
was observed in T. cruzi populations from in vitro condi-
tions. The primary isolate from Patient 2 and parasites iso-
lated after passage in immunosuppressed mice displayed
identical isoenzymatic patterns (not shown).
Discussion
By using different molecular markers it was possible to
identify taxonomically, at species level, the primary iso-
lates. Different zymodemes belonging to domestic and
sylvatic cycles as well as distinct kDNA restriction profiles
were also observed in the strains analyzed. In addition a
synthetic oligonucleotide specific for the subgenus Schizo-
trypanum [25] was used as probe to confirm the character-
ization of the primary isolates as T. (S..) cruzi (not
shown). The primary isolate of Patient 1 was typed as a
variant of the zymodeme 2. In this patient the reactivation
of the disease was observed. The CD4 lymphocyte counts
remained under 200 cells/mm3 during one year demon-
strating the severity of the immunosuppression[15]. The
other patient (Patient 2), presenting cardiac manifestation
of chronic Chagas disease, showed no clinical and parasi-
tological evidence of reactivation at the moment of the
strain isolation [16]. The primary isolate of this patient,
although presenting a more divergent isoenzymatic pat-
tern was considered as belonging to sylvatic zymodemes.
The primary isolate from Patient 1 was composed at least
by three distinct populations indicating the polyclonality
of the initial infection and selection of subpopulations
under experimental conditions. Mixed infections with dis-
tinct populations of T. cruzi in natural human infections
[26,27] and in triatomine vectors [28] have been reported
in literature. As well as, cloned populations in T. cruzi and
Leishmania parasites have shown evidence of heterogene-
ity [29,30].
In the present work selective pressures acting on the para-
site could have induced a variation in the kDNA minicir-
cle classes. The observed genetic variability occurred when
a unique genotypic profile was observed in vivo (kDNA
profile II) independent of the initial inoculum. Such vari-
ability might reflect a shift in specific classes of minicircles
[31] or alternatively, an endogeneous generation of new
polymorphisms [10]. Corroborating to such hypothesis
cross-hybridizations using homologous probes (kDNA
profile I and II) revealed strong sequence homology indi-
cating a close-genetic relationship. Although kDNA pro-
file III was the most differentiated, homologous
sequences were also present in the kDNA from the pri-
mary human isolate (kDNA profile I). Such observation
indicates that these sequences are present in the kDNA of
the parental strain, or alternatively, parasite populations
belonging to kDNA profile III are present in a low percent-
age in the whole initial population. Conversely, the
absence of cross-hybridization could also indicate the
possibility of specific minicircle classes being present in
different percentages in the two T. cruzi subpopulations.
Isoenzymatic analysis also confirmed the distinctiveness
of the subpopulation selected in vitro. Probably the three
observed profiles do represent populations of varying
composition. Further clonal analysis of such populations
will possibly solve this question.
The genetic diversity observed in these populations or the
emergence of minor parasite subpopulations, as a conse-
quence of selection, can be regarded as a way of conferringKinetoplastid Biology and Disease 2003, 2 http://www.kinetoplastids.com/content/2/1/17
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selective advantages to the parasite. Reinforcing this argu-
ment, it was recently reported the presence of certain phe-
notypic patterns of parasites isolated from HIV positive
patients [32]. The authors addressed the possibility that
the immune system could select virulent from avirulent
populations. In the present work, only one genetic profile
(kDNA profile II) was observed in mice. This finding sug-
gests that the selected population is probably more
adapted to the stress conditions in vivo. In fact, the emer-
gence of the kDNA profile II after inoculation in vivo of
populations from profile III corroborates such a state-
ment. As in the second strain (Patient 2) no marked
Agarose gel electrophoresis showing Hinf-I kDNA restriction profiles of T. cruzi isolated from patient 1 and populations recov- ered in vivo and in vitro Figure 2
Agarose gel electrophoresis showing Hinf-I kDNA restriction profiles of T. cruzi isolated from patient 1 and populations recov-
ered in vivo and in vitro. A) M-DNA marker: λ Hind II/ox Hae III, 1-kDNA profile I, 2-kDNA profile II, 3-kDNA profile III, 4–5-
T. cruzi populations recovered after passage in immunosuppressed mice (kDNA profile II); B) enlarged photograph of kDNA 
minicircle regions showing the heterogeneity in fragments ranging from 600 to 1500 bp.Kinetoplastid Biology and Disease 2003, 2 http://www.kinetoplastids.com/content/2/1/17
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genetic difference was observed before and after immuno-
suppression in mice, a strain-dependent phenomenon
can also be a plausible explanation. The fact that T. cruzi
strains react differently to the immunosuppressive effect
of cyclophosphamide [33] may perhaps sustain such
supposition.
The biological and genetic heterogeneity of circulating
strains of T. cruzi can make it difficult to interpret the dif-
ferent manifestations of the disease and also to make
correlation between strains and specific clinical traits.
However, different T. cruzi strains have been shown to be
involved in pathologies of the autonomic nervous system
in mice [34]. On the other hand, it was also reported that
the reactivation of Chagas disease in HIV positive patients
was not correlated with a particular T. cruzi genotype [35].
Conclusion
As final remarks, it is reasonable to suppose that the
immunological condition of the patient, associated or not
to the reactivation of the infection, and also the strain of
the parasite may have an important role during the course
of the disease. The in vivo mechanism that generates para-
site genetic variability or the participation of the selection
under stress conditions will require further investigation.
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Southern blot hybridization with homologous kDNA probes and corresponding autoradiographies Figure 3
Southern blot hybridization with homologous kDNA probes and corresponding autoradiographies. A) Agarose gel electro-
phoresis showing Hinf-I kDNA restriction profiles: M-DNA marker: λ Hind II/ox Hae III, 1-kDNA profile I, 2-kDNA profile II, 
3-kDNA profile III, 4–5-T. cruzi populations after passage in immunosuppressed mice (kDNA profile II). B) autoradiography 
after hybridization with kDNA profile I used as probe. C) autoradiography after hybridization with kDNA profile III as probe. 
(D) autoradiography after probing with kDNA profile II.Kinetoplastid Biology and Disease 2003, 2 http://www.kinetoplastids.com/content/2/1/17
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